|
DIAJ
|
Benefit/Risk Estimates in Clinical Trials
|
Adil E. Shamoo
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Japanese Guideline on Global Clinical Trials:
Statistical Implications and Alternative Criteria
for Assessing Consistency
|
Florence Le Maulf,Kevin J. Carroll
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Decision Making for a Companion Diagnostic
in an Oncology Clinical Development Program
|
Bernard Fine,Lee Kaiser
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Establishing a Complete Drug Information Triad:
Academic, Industry, and Hospital Training
|
Elizabeth S Miller,Katie J. Suda,Anne M. Hurley,Mina Tadrous,Daniel Gharbawy
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Reporting of Adverse Drug Reactions
by Community Pharmacists:
A Qualitative Study in Quebec
|
Benoit Rouleau
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Technical Requirements for
Biopharmaceutics Classification
System–based Biowaiver in China
|
Ning Zhang
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Results of a Survey of PhRMA Member Companies
on Practices Associated With Multiregional
Clinical Trials
|
Nick R Scott,Tonya L Houck,Yoko Tanaka,Bruce Binkowitz,Belinda Field,Ekopimo O. Ibia,Andy Lee,Steven Talerico
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Consistency of Treatment Effect Across Regions
in Multiregional Clinical Trials, Part 2:
Monitoring, Reporting, and Interpretation
|
Soo P. Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi Ikeda
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies
|
Zheng Su
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Optimal Allocation of Prognostic Factors in Randomized Preclinical Animal Studies
|
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Review of: Fundamentals of US Regulatory Affairs, 7th ed.
|
Edward Tabor
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Certification for the Medical Science Liaison: An Idea Whose Time Has come---or Not
|
Kenneth L Massey,Jane Chin,Jimmy Thomas Black
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Medical Information Services in the Age of Social Media and New Customer Channels
|
Lesley S. Fierro,Poonam A. Bordoloi,Michelle Clausen,Krupa Paranjpe,Andrew Gazo
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Clinically Important Effects in New Drug Development
|
Satoshi Hashigaki,Kanae Togo,Takashi Moriya,Keiji Imai
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Consistency of Treatment Effect Across Regions
in Multiregional Clinical Trials, Part 1:
Design Considerations
|
Soo P. Ouyang,Paul P. Gallo,Shailendra S. Menjoge,Yoko Tanaka,Bruce Binkowitz,Ekopimo O. Ibia,Gang Li,Hui Quan,Xiaolong Luo,Joshua Chen,Steven Talerico,Kimitoshi Ikeda
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Assessment of Electronic Drug Information Research Availability in Alabama Pharmacies
|
Michael G Kendrach,Bob Schrimsher,Maisha Kelly Freeman
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Content Analysis of Off-label Drug Use: Reporting Print Media Coverage
|
David A. Holdford,Avani D Joshi
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Failure to Communicate: Medication Guide or Memory ?
|
Louis A Morris,Morris S Whitcup
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Evaluation of Drug Adverse Event Intake and Reporting in a Medical Information Service
|
Robert J. Fuentes,Michael Hoopes,Gregory M Susla,Pamela D Allen
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Impact of Different Regulatory Requirements
for Trial Endpoints in
Multiregional Clinical Trials
|
Cynthia J. Girman,Shailendra S. Menjoge,Bruce Binkowitz,Carmen Mak,Anupam Agarwal,Ekopimo O. Ibia,Joshua Chen
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Validation of Decision-enabling Tools: Showing That the Model Is Useful
|
Stig J Wiklund
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Points to Consider in Defining Region
for a Multiregional Clinical Trial:
Defining Region Work Stream in
PhRMA MRCT Key Issue Team
|
Michael A Rabbia,Yoko Tanaka,Bruce Binkowitz,Carmen Mak,Ekopimo O. Ibia,Brent Burger,Joshua Chen,Alex Zolotovitski
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
A Benefit-risk Model to Facilitate DMC-sponsor Communication and Decision Making
|
Andreas I. Sashegyi
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Letter to the Editor: Selection of the Time Points for a Thorough QTc Study
|
Norman Stockbridge,Joanne Zhang
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Multiregional Clinical Trials: An Introduction From an Industry Perspective
|
Bruce Binkowitz,Ekopimo O. Ibia
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
A Longitudinal Model and Graphic for Benefit-risk Analysis, With Case Study
|
Jonathan D. Norton
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Letters to the Editor
|
Norman Stockbridge,Lawrence Z Satin,Eoin O'Brien
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Platelet Aggregation Quality Control in a Multicenter Phase 2 Clinical Trial
|
James McRedmond
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Program Chair Reflects Upon DIA 2011
|
Kenneth A. Getz
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Ten-year Experience of the Evaluation of Ethnic Sensitivity Data
|
Chia-Ling Hsiao
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Editor's Commentary: Letters to the Editor, a New Publishing Partner, and Benefit-risk Estimation
|
Rick Turner
|
2011
|
45(05)
|
View Abstract
|
|
DIAJ
|
Letter to the Editor
|
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Fewer Drugs, Shorter Lives, Less Prosperity: The Impact of Comparative Effectiveness Research on Health and Wealth
|
Peter J. Pitts
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Preparing for a Safety Inspection
|
Steve Jolley
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Associate Editor's Commentary: The Danger of Shorting Drug Shortages
|
Peter J. Pitts
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Commentary: The Real-world Convergence of Comparative Effectiveness Research and Risk- Benefit Assessment
|
John Doyle
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
Editor's Commentary: A Time for Reflection and Anticipation
|
Rick Turner
|
2011
|
45(06)
|
View Abstract
|
|
DIAJ
|
DIA 2011 47th Annual Meeting Student Poster Abstracts
|
Nicholas H. Schluterman,Anne-Sophie Auroux,Mohammed Hamdan Al Rubaie,Jie Rena Sun,Jingjing Liu,Kaushal Vinaykumar Sheth,Gabriel Meister,Brian Claggett,Danish Arora,Manasi Datar,Shaunak Praful Kulkarni,Michelle P. Pernice,Andrew W. York,Digvijay Chandrakant Yeola,Joseph Mburu,Nikita Somani
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Expediting Patient Access to New Medicines: A Call to Action, London, January 26-27, 2010
|
Peter J. Pitts,Werner Cautreels,Mary Baker
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
5th Annual Cardiovascular Risk Assessment Summit
|
Lawrence Z Satin,David E. Gutstein
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Review of the 9th Middle East Regulatory Conference
|
Adrian Ball,Mike Stuart Fallows
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Review of International Pharmaceutical Product Registration, 2nd ed.
|
Edward Tabor
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Implementation of an Electronic Medical Information Request System for Field-generated Information Inquiries
|
Rommel Fernandez,Barbara Schreiner,Edward Bezarro,Helen Yin Yu,Jimmy Thomas Black
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Effect of Direct-to-Consumer Drug Advertising Exposure on Information Search
|
Clive Mario Mendonca,David J McCaffrey,Benjamin F. Banahan III,Jonn P. Bently,Yi Yang
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Using Real-time Data to Drive Better Decisions, Faster
|
Paula Brown Stafford,Andrew Garrett
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Covariate-adjusted Difference in Proportions From Clinical Trials Using Logistic Regression and Weighted Risk Differences
|
Miaomiao Ge,L. Kathryn Durham,R. Daniel Meyer,Wangang Xie,Neal Thomas
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Multiple-stage Sampling Procedure for Lot Release With Consideration of oth Manufacturer's and Consumer's Risk
|
Boguang Zhen,Tie-Hua Ng,Henry Hsu
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Optimal Sample Size Allocation in a Thorough QTc Study
|
Joanne Zhang
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Are Pharmacists a Viable Channel for Education About Clinical Trial Participation?
|
Diane Simmons,Jill Chappell,Kenneth A. Getz,Zachary P Hallinan,Brian P. Schrock,Dorothy L Smith
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Phase 2 Clinical Development in Treating Chronic Diseases
|
Naitee Ting
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Evaluation of Data Entry Errors and Data Changes to an Electronic Data Capture Clinical Trial Database
|
Jules T. Mitchel,Yong Joong Kim,Joonhyuk Choi,Glen D Park,Silvana Cappi,David Horn,Morgan Kist,Ralph B. D'Agostino
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Variability in Protocol Design Complexity by Phase and Therapeutic Area
|
Kenneth A. Getz,Rafael A. Campo,Kenneth I. Kaitin
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Editor's Commentary: Additional Associate Editors, New Submission Category, and Meta-methodology
|
Rick Turner
|
2011
|
45(04)
|
View Abstract
|
|
DIAJ
|
Proceedings of the DIA WOrkshop on Multiregional Clinical Trials, October 26-27, 2010
|
Ekopimo O. Ibia,Bruce Binkowitz
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Factors Influencing Investigative SIte Willingness and Ability to Participate in Clinical Trials
|
Mary Jo Lamberti,Rachael Zuckerman,Deborah Howe,Lisa E. Shapiro,Kenneth A. Getz
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Assessing a Drug's Proarrhythmic Liability: An Oerview of Computer SImulation Modeling, Nonclinical Assays, and the Thorough QT/QTc Study
|
Lawrence Z Satin,Timothy Lee Durham,Rick Turner
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Time-Cost Optimization of Complex Clinical Trials
|
Douglas Gregory
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Call Handling in the Pharmaceutical Industry: A Benchmarking Survey
|
Catherine J Nojiri,Chandni Patel
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Conditional Type I Error Rate for Superiority Test Conditioned on Establishment of Noninferiority in Clinical Trials
|
Jason Yuan,Tiejun Tong,Tie-Hua Ng
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
A Two-Stage Adaptive Design in Phase 2 Clinical Trials for Acute Treatment of Migraine
|
Xiaoyin Frank Fan,Chris Assaid,Yang Joy Ge,Tony W. Ho
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Statistical Analysis for Long-term Stability Studies with Multiple Storage Conditions
|
Edwin Van den Heuvel,Osama Almalik,Michiel Nijhuis,Edward I. Warner
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
A Meta-analysis to Asess the FDA DAVP's TLOVR Algorithm in HIV Submissions
|
Fraser Smith,Thomas Hammerstrom,Greg Soon,Susan Y Zhou,Baibai Chen,Yabling Mai,Kimberly A. Struble,Mohammad Huque
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
The Physicians' Labeling Rule: An Evaluation of Compliance
|
Amy L. Ebel,Thomas G Cantu,Stuart Hobbs,Paula R. Rogenes,Melissa H Beaman,MaryAnn E Ziemba
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Measuring the Incidence, Causes, and Repercussions of Protocol Amendments
|
Kenneth A. Getz,Rachael Zuckerman,Anne B. Cropp,Anna L Hindle,Randy Krauss,Kenneth I. Kaitin
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Substantial Evidence: When is a Single Trial Sufficient for Approval and Promotion?
|
David Coutant,David Riggs,Elizabeth Van Sant Hoffman
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
FDAAA Basic Results Reporting: First Experience and Challenges
|
Hans-Theo Forst,Robert Paarlberg,Elizabeth Roberts
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Focus on the Cardia Safety Research Consortium
|
Mitchell W. Krucoff
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Why ABPM Should Be Mandatory in All Trials of Blood Pressure - Lowering Drugs
|
Eoin O'Brien
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Associates Editor's Commentary: Innovation Nation
|
Peter J. Pitts
|
2011
|
45(03)
|
View Abstract
|
|
DIAJ
|
Editor's Commentary: Regulatory Science and the Science of Safety
|
Rick Turner
|
2011
|
45(03)
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
November 01 2012
|
Issue 9
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
August 01 2012
|
Issue 8
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
May 01 2012
|
Issue 7
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
February 01 2012
|
Issue 6
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
November 01 2011
|
Issue 5
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
August 01 2011
|
Issue 4
|
View Abstract
|
|
CHNNEWS
|
Global Pharmaceutical Forum (In Chinese)
|
|
May 01 2011
|
Issue 3
|
View Abstract
|
|
GF
|
Global Forum
|
|
June 01 2013
|
13(03)
|
View Abstract
|
|
GF
|
Global Forum
|
|
April 01 2013
|
13(02)
|
View Abstract
|
|
GF
|
Global Forum
|
|
February 01 2013
|
13(01)
|
View Abstract
|
|
GF
|
Global Forum
|
|
December 01 2012
|
12(06)
|
View Abstract
|
|
GF
|
Global Forum
|
|
October 01 2012
|
12(05)
|
View Abstract
|
|
GF
|
Global Forum
|
|
August 01 2012
|
12(04)
|
View Abstract
|
|
GF
|
Global Forum
|
|
June 01 2012
|
12(03)
|
View Abstract
|
|
GF
|
Global Forum
|
|
April 01 2012
|
12(02)
|
View Abstract
|
|
GF
|
Global Forum
|
|
February 01 2012
|
12(01)
|
View Abstract
|
|
GF
|
Global Forum
|
|
December 01 2011
|
11(06)
|
View Abstract
|
|
GF
|
Global Forum
|
|
October 01 2011
|
11(05)
|
View Abstract
|
|
GF
|
Global Forum
|
|
August 01 2011
|
11(04)
|
View Abstract
|
|
GF
|
Global Forum
|
|
June 01 2011
|
11(03)
|
View Abstract
|
|
GF
|
Global Forum
|
|
April 01 2011
|
11(02)
|
View Abstract
|